ATEC Outperforms Expectations With 24% Growth In 2019
With 12 new product launches and improvement across all major growth metrics, ATEC drove 24% growth in 2019 as it continues to reinvent itself. Mar 09, 2020
Conformis Growth Hamstrung by Aetna Denials in 2019
Unable to offset the loss of Aetna coverage and the lack of a cementless knee, Conformis sales declined in the low double-digits in 2019. Mar 04, 2020
Vericel’s High Growth Trajectory Has Staying Power
The company's MACI product drive 35% growth in 2019 and has penetrated just a quarter of Vericel's target addressable market of 5,000 surgeons. Feb 27, 2020
Orthofix’s Growth Slows as It Struggles to Fill Leadership Roles
Continuing vacancies in key leadership and commercial channel restructuring caused uncertainty and slower sales for Orthofix in 2019. Feb 26, 2020
NuVasive Hits $1 Billion in Spine Sales for 2019
Improving MIS adoption and new products drove NuVasive’s growth in 2019 but the company also announced the launch of its Pulse system will be delayed. Feb 26, 2020
Globus Notches Third Straight Year of Double-Digit Growth in 2019
Despite supply issues in biologics and flat enabling technology sales, Globus had record revenues in 4Q and a third consecutive year of double-digit growth. Feb 25, 2020
Anika Expects Busy 2019 Will Spur Massive 2020 Growth
Anika has taken steps in its evolution to a global commercial company with the launch of TACTOSET as well as the acquisitions of Parcus and Arthrosurface. Feb 24, 2020
Smith+Nephew Drives 4Q Growth on Reinvigorated Sports Medicine
After struggling with an aging portfolio of sports medicine enabling technology, Smith+Nephew returned that segment to growth leading to a strong 4Q finish. Feb 24, 2020
Integra Primed for Orthopedic Growth After Transitional 2019
Integra LifeSciences increased its supply capacity and overhauled its commercial organization in 2019 to accelerate the growth of its orthopedic franchise. Feb 21, 2020
Late-Quarter Infuse Headwinds Blunt Medtronic’s Growth
Medtronic’s FY3Q20 growth was surprisingly light due to headwinds around Infuse orders, but the enabling technology continues to drive implant sales. Feb 19, 2020
